The management of dietary sodium intake in individuals with chronic kidney disease (CKD) is of clinical and public health significance for multiple reasons. First, ~10% of the population worldwide has CKD,1 and CKD’s ranking as a cause of death globally increased from number 27 in 1990 to number 18 in 2010.2 Second, the costs associated with CKD are staggering; in the United States, treatment costs exceed $48 billion per year,3 and in the Netherlands, the annual per-patient cost for hemodialysis is $83,736.